Raytel and MDI settle litigation
Imaging services firms Raytel Medical and Medical Diagnostics have settled their dispute related to Massachusetts Mobile Imaging Venture, a joint venture between the two companies. Under the terms of the settlement, Raytel will receive approximately
Imaging services firms Raytel Medical and Medical Diagnostics have settled their dispute related to Massachusetts Mobile Imaging Venture, a joint venture between the two companies. Under the terms of the settlement, Raytel will receive approximately $230,000 from an escrow account associated with the disputed venture. In addition, both parties will drop all claims and related litigation regarding the joint venture and certain other claims pending in state court, according to San Mateo, CA-based Raytel. The dispute began before MDI was acquired by USDL earlier this year.
In other Raytel news, the company announced that its application to operate an outpatient cardiovascular diagnostic facility in Fremont, CA, has been denied by the California Department of Health Services. The company intends to file an administrative appeal. On the positive side, Raytel this month finalized an agreement to develop a heart center at Baptist Hospital of Southeast Texas in Beaumont, TX.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can a Six-Minute MRI Facilitate Detection of Multiple Sclerosis?
May 23rd 2025Recognition of the central vein sign with a six-minute MRI demonstrated comparable sensitivity for multiple sclerosis (MS) detection in comparison to oligoclonal band (OCB) assessment, which requires lumbar puncture, according to newly published research.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
